A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO-B Inhibitors [2015-Till Date]

被引:5
作者
Thomas, Riya Rachel [1 ]
Chandran, Namitha [1 ]
Parambi, Della Grace Thomas [2 ]
Kumar, Sunil [1 ]
Alsahli, Tariq G. [3 ]
Verma, Shivani [4 ,5 ]
Al-Sehemi, Abdullah G. [6 ]
Mathew, Bijo [1 ]
机构
[1] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmaceut Chem, AIMS Hlth Sci Campus, Kochi 682041, India
[2] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka 72341, Aljouf, Saudi Arabia
[3] Jouf Univ, Coll Pharm, Dept Pharmacol, Sakaka 72341, Aljouf, Saudi Arabia
[4] Graph Era Hill Univ, Sch Pharm, Dehra Dun 248002, India
[5] Graph Era Deemed Univ, Dept Pharm, Dehra Dun 248002, India
[6] King Khalid Univ, Coll Sci, Dept Chem, Abha 61413, Saudi Arabia
关键词
Molecular dynamics; Monoamino oxidase B; Selective inhibitors; Chalcone derivatives; Coumarin derivatives; Chromone derivatives; Docking study; MONOAMINE-OXIDASE-B; PRINCIPAL COMPONENT; VALID SCAFFOLD; SIMULATIONS; POTENT; DERIVATIVES; FLAVONOIDS; RESIDUES; DOCKING; HYBRIDS;
D O I
10.1002/slct.202401709
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Molecular dynamics (MD) simulation is an in silico method used in the biomolecular level of research to study how the protein interacts with the target with time. It provides a detailed information of the protein dynamics and ligand structure with the crucial amino acid interactions. Monoamine oxidase B (MAO-B) is a crucial isoenzyme responsible for the catalyses of oxidative deamination of various biogenic amines in the brain and peripheral tissues. The selective inhibitors of MAO-B are considered as the management of symptoms of neurodegenerative disorders like Alzheimer's disease(AD) and Parkinson disease(PD). Recently the structural scaffolds containing chalcones, coumarins and chromones derived candidates shown potent, selective, competitive and reversible type of MAO-B inhibitors. The structural similarities between the above scaffolds can produce almost similar type of interactions in the inhibitor binding cavity of MAO-B. Numerous molecular simulation reports were supported by the above mentioned fact. The current review focus on the last ten year molecular dynamics report of chalcones, coumarins and chromones towards MAO-B inhibition. The review also focuses on the software details used in the MD dynamics simulation and the structural requirement from each class of compound for the recognition of MAO-B inhibitory activity. The current review focus on the detailed molecular dynamics simulation studies of chalcones, coumarins and chromones in the inhibitor binding cavity of MAO-B. The review also gave a detailed information about the structural requirements of these class of derivatives for the recognition of MAO-B. image
引用
收藏
页数:31
相关论文
共 143 条
[51]   CHARMM-GUI 10 years for biomolecular modeling and simulation [J].
Jo, Sunhwan ;
Cheng, Xi ;
Lee, Jumin ;
Kim, Seonghoon ;
Park, Sang-Jun ;
Patel, Dhilon S. ;
Beaven, Andrew H. ;
Lee, Kyu Il ;
Rui, Huan ;
Park, Soohyung ;
Lee, Hui Sun ;
Roux, Benoit ;
MacKerell, Alexander D., Jr. ;
Klauda, Jeffrey B. ;
Qi, Yifei ;
Im, Wonpil .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2017, 38 (15) :1114-1124
[52]   Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations [J].
Jose, Jisna ;
Varughese, Jibin K. ;
Parvez, Mohammad Khalid ;
Mathew, Thomas V. .
JOURNAL OF MOLECULAR MODELING, 2024, 30 (04)
[53]   A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease [J].
Jost, Wolfgang H. .
JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) :723-736
[54]   Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition [J].
Kamel, Nahla N. ;
Aly, Hanan F. ;
Fouad, Ghadha I. ;
Abd El-Karim, Somaia S. ;
Anwar, Manal M. ;
Syam, Yasmin M. ;
Elseginy, Samia A. ;
Ahmed, Kawkab A. ;
Booles, Hoda F. ;
Shalaby, Mohamed B. ;
Khalil, Wagdy K. B. ;
Sandhir, Rajat ;
Deshwal, Sonam ;
Rizk, Maha Z. .
RSC ADVANCES, 2023, 13 (27) :18496-18510
[55]   Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship [J].
Keri, Rangappa S. ;
Budagumpi, Srinivasa ;
Somappa, Sasidhar Balappa .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) :915-931
[56]   Structure-based identification of potential SARS-CoV-2 main protease inhibitors [J].
Khan, Shama ;
Fakhar, Zeynab ;
Hussain, Afzal ;
Ahmad, Aijaz ;
Jairajpuri, Deeba Shamim ;
Alajmi, Mohamed F. ;
Hassan, Md. Imtaiyaz .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (08) :3595-3608
[57]   Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders [J].
Koyiparambath, Vishal Payyalot ;
Oh, Jong Min ;
Khames, Ahmed ;
Abdelgawad, Mohamed A. ;
Nair, Aathira Sujathan ;
Nath, Lekshmi R. ;
Gambacorta, Nicola ;
Ciriaco, Fulvio ;
Nicolotti, Orazio ;
Kim, Hoon ;
Mathew, Bijo .
PHARMACEUTICS, 2021, 13 (06)
[58]   Inhibition of monoamine oxidases by benzimidazole chalcone derivatives [J].
Krishna, Athulya ;
Lee, Jiseong ;
Kumar, Sunil ;
Sudevan, Sachithra Thazhathuveedu ;
Uniyal, Prerna ;
Pappachen, Leena K. ;
Kim, Hoon ;
Mathew, Bijo .
APPLIED BIOLOGICAL CHEMISTRY, 2023, 66 (01)
[59]   A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors [J].
Krishna, Athulya ;
Kumar, Sunil ;
Sudevan, Sachithra Thazhathuveedu ;
Singh, Ashutosh Kumar ;
Pappachen, Leena K. ;
Rangarajan, T. M. ;
Abdelgawad, Mohamed A. ;
Mathew, Bijo .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (06) :697-714
[60]   Recent developments on the structure-activity relationship studies of MAO inhibitors and their role in different neurological disorders [J].
Kumar, Bhupinder ;
Sheetal ;
Mantha, Anil K. ;
Kumar, Vinod .
RSC ADVANCES, 2016, 6 (48) :42660-42683